Inhibition of inflammation cascades by mesenchymal stem cells

The term "Inhibition of inflammation cascades by mesenchymal stem cells" does not refer to a single molecular target but rather describes the broad immunomodulatory actions exerted by mesenchymal stem cells (MSCs). These multipotent stromal cells can home to sites of tissue injury or inflammation where they modulate both innate and adaptive immune responses. Mechanistically, MSCs secrete various soluble factors—including anti-inflammatory cytokines like interleukin 10 (IL‑10) and transforming growth factor beta (TGF‑β)—and interact directly with immune effector cells such as macrophages, dendritic cells, natural killer cells, B lymphocytes, and T lymphocytes. They promote the polarization of macrophages toward an anti-inflammatory M2 phenotype while suppressing pro-inflammatory responses from other immune subsets. Through these actions—often mediated via secreted exosomes as well—MSCs help resolve excessive inflammation while supporting tissue repair processes. This makes them promising candidates for treating inflammatory diseases such as autoimmune disorders, graft-versus-host disease after transplantation, allergic conditions, and organ rejection episodes[1][2][3][4]. However, because this is a complex cellular process rather than a discrete protein or receptor targetable by small molecules or antibodies—and because "inhibition of inflammation cascades by mesenchymal stem cells" is not itself the name of any canonical molecule—the entry should be considered incorrect if used in contexts requiring standard drug targets. Note: The phrase provided refers to an entire biological process mediated by living therapeutic agents—not a canonical druggable target like an enzyme or receptor—and thus does not fit conventional pharmacological classification schemes.

Other names

Mesenchymal stem cell-mediated immunomodulationMSC immunosuppressionMSC anti-inflammatory effects

- Secretion of anti-inflammatory cytokines (e.g., IL‑10, TGF‑β) - Suppression of pro-inflammatory cytokine production (e.g., TNF‑α, IFN‑γ) - Polarization of macrophages from M1 to M2 phenotype[2][4] - Induction and expansion of regulatory T cells (Treg) and Th2 cells[1][3] - Suppression of dendritic cell maturation and function[1][3]